Rhumbline Advisers grew its holdings in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 0.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 250,121 shares of the electronics maker’s stock after acquiring an additional 1,194 shares during the period. Rhumbline Advisers owned 0.26% of Dolby Laboratories worth $19,534,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its position in Dolby Laboratories by 82.7% in the fourth quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock worth $28,000 after acquiring an additional 163 shares in the last quarter. Nisa Investment Advisors LLC grew its position in Dolby Laboratories by 436.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock worth $29,000 after acquiring an additional 301 shares in the last quarter. Mather Group LLC. grew its position in Dolby Laboratories by 36.8% in the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock worth $41,000 after acquiring an additional 142 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of Dolby Laboratories by 22.7% during the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock worth $60,000 after buying an additional 146 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Dolby Laboratories by 207.5% during the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock worth $61,000 after buying an additional 525 shares during the period. 58.56% of the stock is owned by institutional investors.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, SVP John D. Couling sold 7,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $80.50, for a total value of $563,500.00. Following the completion of the sale, the senior vice president now directly owns 106,806 shares of the company’s stock, valued at $8,597,883. This represents a 6.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Mark Andrew Sherman sold 12,338 shares of the stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total transaction of $963,351.04. Following the completion of the transaction, the executive vice president now owns 62,397 shares of the company’s stock, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 126,838 shares of company stock valued at $10,379,431 in the last ninety days. Company insiders own 38.39% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on Dolby Laboratories
Dolby Laboratories Price Performance
Shares of Dolby Laboratories stock opened at $82.36 on Friday. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66. The firm has a fifty day moving average price of $80.56 and a two-hundred day moving average price of $76.25. The company has a market cap of $7.86 billion, a PE ratio of 30.28 and a beta of 0.98.
Dolby Laboratories Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.53%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- The 3 Best Blue-Chip Stocks to Buy Now
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Want to Profit on the Downtrend? Downtrends, Explained.
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.